Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ANIK
ANIKA THERAPEUTICS, INC.
NASDAQ
$21.10
▲ UP 1.25% (0.26)

KEY STATISTICS

Market Cap$282.38 M
52w High$22.88
52w Low$8.37
Dividend Yield—
Frequency—
P/E43.06
Volume98.94K
Shares Out.13.38M

COMPANY

LEADERSHIP

Stephen D. Griffin
CHIEF EXECUTIVE
Stephen D. Griffin

COMPENSATION 2026

Salary$750,397
Stock Awards$3,476,669
Incentive Plan Pay$0
All Other Comp.$22,252
Total$4,887,318

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 3, 1993
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
235

PRICE TARGET

Target High$21.00
Target Low$21.00
Target Median$21.00
Target Consensus$21.00

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$29.74M
NOV
4
WED

PRICE

$21.10 ▲ UP 1.25% (+$0.26)
$21.00$21.20$21.409:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM21.10

About Anika Therapeutics, Inc.

https://www.anika.com ↗

Anika Therapeutics, Inc. develops and commercializes hyaluronic acid-based products for orthopedic, regenerative, soft tissue repair, and non-orthopedic applications globally, focusing on early intervention and joint preservation.

INDUSTRY

Medical - Specialties

A PRODUCT ANIKA THERAPEUTICS, INC. IS KNOWN FOR

Integrity™ Implant System
Integrity™ Implant System

Anika's hyaluronic acid-based scaffold for soft tissue reinforcement, especially in rotator cuff repairs, has recently launched in the U.S., gaining strong market traction and emphasizing the company's focus on regenerative and early intervention ...

COMPETITORS

COMPETITOR
BVS COMPARE
OFIX COMPARE
SNN COMPARE
SYK COMPARE
ZBH COMPARE

Revenue by Products

IconPRODUCTQ4-2023Q1-2024Q2-2024Q3-2024
Joint Preservation and Restoration$15.3M $13.84M ▼$13.55M ▼$11.95M ▼
NonOrthopedic$2.6M $2.36M ▼$1.71M ▼$2.38M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$17.45M $18.32M ▲$18.53M ▲$19.8M ▲
Europe$5.67M $6M ▲$6.67M ▲$6.84M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
77
LISTED HERE
15
RANKED BY POSITION SIZE
VTI
0.00% · 397.8K
DX2E.DE
0.95% · 318.5K
IWM
0.01% · 307.3K
FSMD
0.08% · 103.9K
SCHA
0.01% · 66.3K
DFSV
0.01% · 58.8K
SLY
0.04% · 27.0K
AVSC
0.02% · 24.0K
GSSC
0.04% · 19.5K
PRFZ
0.01% · 15.4K
JPSE
0.02% · 5.5K
RSSL
0.01% · 5.4K
SQLV
0.25% · 5.0K
URTY
0.00% · 465
DM
DMRS
0.04% · 426

INSTITUTIONAL OWNERSHIP

SHARES OWNED
90.53%
HOLDERS
221
TOP 12 OF 221 · RANKED BY POSITION SIZE
Blackrock, Inc.
1.7M sh · $16.37M
Trigran Investments, Inc.
1.6M sh · $15.24M
Blackrock Inc.
1.6M sh · $40.7M
Caligan Partners LP
1.4M sh · $13.49M
Blackrock Fund Advisors
1.2M sh · $57.46M
Morgan Stanley
872.1K sh · $12.64M
Vanguard Group Inc
780.7K sh · $7.34M
Acadian Asset Management LLC
632.8K sh · $5.94M
Dimensional Fund Advisors LP
601.2K sh · $5.65M
Aqr Capital Management LLC
559.8K sh · $8.19M
Capital Management Corp /Va
551.2K sh · $5.18M
Boothbay Fund Management, LLC
539.6K sh · $5.07M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Tom Malinowski
Tom Malinowski
Purchase
2020-03-02

INSIDER TRADES

★
DIRECTOR
Fischetti Gary P
Purchase · 1.0K shares
2026-08-04
★
DIRECTOR
HENNEMAN JOHN B III
Purchase · 10.4K shares
2026-06-18
★
DIRECTOR
Fischetti Gary P
Purchase · 10.4K shares
2026-06-18
★
DIRECTOR
Richard Stephen
Purchase · 10.4K shares
2026-06-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
OUTPERFORM 1
2 GRADES IN THE LAST 12 MONTHS
B. Riley Securities BUY Barrington Research OUTPERFORM

SECTORS PEERS

PEERPRICE
AVR$8.74COMPARE
LUCD$0.99COMPARE
MXCT$1.22COMPARE
APYX$3.08COMPARE
ANIX$3.48COMPARE
LNSR$8.30COMPARE
OWLT$4.99COMPARE
RPID$1.57COMPARE